Speaker Info
HIV TREATMENT AND PREVENTION: NEW OPPORTUNITIES TO OPTIMIZE DRUG DOSING, ADHERENCE, AND ANTIRETROVIRAL THERAPY
NEXT-GENERATION ISLATRAVIR IMPLANTS PROJECTED TO PROVIDE YEARLY HIV PROPHYLAXIS
Randolph P Matthews
Merck & Co, Inc, Kenilworth, NJ, USA
--:--:--
--:--:--
Placeholder for warning

loading...